Role of IL-1 and TNF in the brain: Twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system

Brain, Behavior, and Immunity

Volumn 21, Issue 3, 2007, Pages 281-289

  Gosselin, David ^a   Rivest, Serge ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Brain diseases; Brain injuries; Innate immunity; Interleukin 1; Microglia; Tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1; TUMOR NECROSIS FACTOR;

BRAIN INJURY; CENTRAL NERVOUS SYSTEM; CLONING; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; LEUKOCYTE; MACROPHAGE; MICROGLIA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNITY, NATURAL; INTERLEUKIN-1; PSYCHONEUROIMMUNOLOGY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846678072     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2006.12.004     Document Type: Review

References (52)

1. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., and Ting J.P. TNFalpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 4 (2001) 1116-1122
2. Baker D., Butler D., Scallon B.J., O'Neill J.K., Turk J.L., and Feldmann M. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24 (1994) 2040-2048
3. Basu A., Krady J.K., and Levison S.W. Interleukin-1: a master regulator of neuroinflammation. J. Neurosci. Res. 78 (2004) 151-156
4. Brenneman D.E., Schultzberg M., Bartfai T., and Gozes I. Cytokine regulation of neuronal survival. J. Neurochem. 58 (1992) 454-460
5. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., and Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2 (1996) 788-794
6. Carswell E.A., Old L.J., Kassel R.L., Green S., Fiore N., and Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72 (1975) 3666-3670
7. DeKosky S.T., Styren S.D., O'Malley M.E., Goss J.R., Kochanek P., Marion D., Evans C.H., and Robbins P.D. Interleukin-1 receptor antagonist suppresses neurotrophin response in injured rat brain. Ann. Neurol. 39 (1996) 123-127
8. Delhase M., Hayakawa M., Chen Y., and Karin M. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284 (1999) 309-313
9. Feuerstein G., Wang X., and Barone F.C. Cytokines in brain ischemia-the role of TNF alpha. Cell. Mol. Neurobiol. 18 (1998) 695-701
10. Fontaine V., Mohand-Said S., Hanoteau N., Fuchs C., Pfizenmaier K., and Eisel U. Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 22 (2002) RC216
11. Fontana A., Weber E., and Dayer J.M. Synthesis of interleukin-1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction?. J. Immunol. 133 (1984) 1696-1698
12. Frei K., Siepl C., Groscurth P., Bodmer S., Schwerdel C., and Fontana A. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur. J. Immunol. 17 (1987) 1271-1278
13. Giulian D. Ameboid microglia as effectors of inflammation in the central nervous system. J. Neurosci. Res. 18 (1987) 155-171 132-153
14. Giulian D., and Robertson C. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann. Neurol. 27 (1990) 33-42
15. Giulian D., and Tapscott M.J. Immunoregulation of cells within the central nervous system. Brain Behav. Immun. 2 (1988) 352-358
16. Giulian D., Chen J., Ingeman J.E., George J.K., and Noponen M. The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J. Neurosci. 9 (1989) 4416-4429
17. Glezer I., Lapointe A., and Rivest S. Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J. 20 (2006) 750-752
18. Higgins G.A., and Olschowka J.A. Induction of interleukin-1β mRNA in adult rat brain. Mol. Brain Res. 9 (1991) 143-148
19. Hirsch E., Irikura V.M., Paul S.M., and Hirsh D. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc. Natl. Acad. Sci. USA 93 (1996) 11008-11013
20. Hosomi N., Ban C.R., Naya T., Takahashi T., Guo P., Song X.Y., and Kohno M. Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 25 (2005) 959-967
21. Iosif R.E., Ekdahl C.T., Ahlenius H., Pronk C.J., Bonde S., Kokaia Z., Jacobsen S.E., and Lindvall O. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J. Neurosci. 26 (2006) 9703-9712
22. Jacobs C.A., Baker P.E., Roux E.R., Picha K.S., Toivola B., Waugh S., and Kennedy M.K. Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor. J. Immunol. 146 (1991) 2983-2989
23. Jian Liu K., and Rosenberg G.A. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic. Biol. Med. 39 (2005) 71-80
24. Laflamme N., and Rivest S. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappa B alpha within specific cellular populations of the rat brain. J. Neurochem. 73 (1999) 309-321
25. Laflamme N., Lacroix S., and Rivest S. An essential role of interleukin-1β in mediating NF-kB activity and COX-2 transcription in cells of the blood-brain barrier in response to systemic and localized inflammation, but not during endotoxemia. J. Neurosci. 19 (1999) 10923-10930
26. Lazovic J., Basu A., Lin H.W., Rothstein R.P., Krady J.K., Smith M.B., and Levison S.W. Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection. Stroke 36 (2005) 2226-2231
27. Loddick S.A., Liu X.J., Lu Z.X., Liu C., Behan D.P., Chalmers D.C., Foster A.C., Vale W.W., Ling N., and DeSouza E.B. Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke. Proc. Natl. Acad. Sci. USA 95 (1998) 1894-1898
28. Minami M., Kuraishi Y., Yabuuchi K., Yamazaki A., and Satoh M. Induction of interleukin-1 beta mRNA in rat brain after transient forebrain ischemia. J. Neurochem. 58 (1992) 390-392
29. Nadeau S., and Rivest S. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and NF-κB activity in the brain during endotoxemia. J. Neurosci. 20 (2000) 3456-3468
30. Nadeau S., and Rivest S. Endotoxemia prevents the cerebral inflammatory wave induced by intraparenchymal lipopolysaccharide injection: role of glucocorticoids and CD14. J. Immunol. 169 (2002) 3370-3381
31. Nadeau S., and Rivest S. Glucocorticoids play a fundamental role in protecting the brain during innate immune response. J. Neurosci. 23 (2003) 5536-5544
32. Nguyen M.D., Julien J.P., and Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration?. Nature Rev. Neurosci. 3 (2002) 216-227
33. Parnet P., Kelley K.W., Bluthe R.M., and Dantzer R. Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior. J. Neuroimmunol. 125 (2002) 5-14
34. Probert L., Akassoglou K., Pasparakis M., Kontogeorgos G., and Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA 92 (1995) 11294-11298
35. Quan N., Whiteside M., Kim L., and Herkenham M. Induction of inhibitory factor kBa mRNA in the central nervous system after peripheral lipopolysaccharide administration: an in situ hybridization histochemistry study in the rat. Proc. Natl. Acad. Sci. USA 94 (1997) 10985-10990
36. Rothwell N.J. Functions and mechanisms of interleukin-1 in the brain. Trends Pharmacol. Sci. 12 (1991) 430-436
37. Rothwell N.J., and Luheshi G.N. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23 (2000) 618-625
38. Rothwell N.J., and Relton J.K. Involvement of interleukin-1 and lipocortin-1 in ischaemic brain damage. Cerebrovasc. Brain Metab. Rev. 5 (1993) 178-198
39. Roux-Lombard P. The interleukin-1 family. Eur. Cytokine Netw. 9 (1998) 565-576
40. Scherbel U., Raghupathi R., Nakamura M., Saatman K.E., Trojanowski J.Q., Neugebauer E., Marino M.W., and McIntosh T.K. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc. Natl. Acad. Sci. USA 96 (1999) 8721-8726
41. Selmaj K.W., and Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23 (1988) 339-346
42. Shirakawa F., Saito K., Bonagura C.A., Galson D.L., Fenton M.J., Webb A.C., and Auron P.E. The human prointerleukin 1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol. Cell Biol. 13 (1993) 1332-1344
43. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu. Rev. Immunol. 21 (2003) 335-376
44. Turrin N.P., and Rivest S. Unraveling the molecular details involved in the intimate control of the immune and neuroendocrine systems: a revised and innovative hypothesis. Experimental Biology and Medicine 229 (2004) 996-1006
45. Turrin N.P., and Rivest S. Tumor necrosis factor alpha but not interleukin 1beta mediates neuroprotection in response to acute nitric oxide excitotoxicity. J. Neurosci. 26 (2006) 143-151
46. Vecil G.G., Larsen P.H., Corley S.M., Herx L.M., Besson A., Goodyer C.G., and Yong V.W. Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J. Neurosci. Res. 61 (2000) 212-224
47. Wajant H., Pfizenmaier K., and Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 10 (2003) 45-65
48. Webb A.C., Collins K.L., Auron P.E., Eddy R.L., Nakai H., Byers M.G., Haley L.L., Henry W.M., and Shows T.B. Interleukin-1 gene (IL1) assigned to long arm of human chromosome 2. Lymphokine Res. 5 (1986) 77-85
49. Yamasaki Y., Suzuki T., Yamaya H., Matsuura N., Onodera H., and Kogure K. Possible involvement of interleukin-1 in ischemic brain edema formation. Neurosci. Lett. 142 (1992) 45-47
50. Yin Y., Henzl M.T., Lorber B., Nakazawa T., Thomas T.T., Jiang F., Langer R., and Benowitz L.I. Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat. Neurosci. 9 (2006) 843-852
51. Zhang J., and Rivest S. Is survival possible without arachidonate metabolites in the brain during systemic infection?. News Physiol. Sci. 18 (2003) 137-142
52. Zhao B.Q., Wang S., Kim H.Y., Storrie H., Rosen B.R., Mooney D.J., Wang X., and Lo E.H. Role of matrix metalloproteinases in delayed cortical responses after stroke, Nat. Med. 12 (2006) 441-445